Acupuncture Therapy and Hypertension
Part of paid clinical trials in Irvine, California.
- Sponsor
- University of California, Irvine
- Study ID
- NCT05530512
- Status
- Recruiting
Conditions
- Mild to Moderate Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- electroacupuncture — OTHERacupuncture needling and stimulation are applied for 30 min
Study Details
Acupuncture therapy will be provided to reduce blood pressure in hypertensive patients. The mild to moderate hypertensive patients will be either on or off hypertensive medications. The course last for 8 weeks and the frequency is once a week.
Key Dates
- Start date
- Jan 1, 2023
- Status verified
- Jul 2025
- Primary completion
- Mar 31, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 72 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Anti-inflammatory EA (AI-EA)Anti-inflammatory electroacupuncture therapy
- Experimental: Sympathoinhibitory EA (SI-EA)sympatho-inhibitory electroacupuncture therapy
- Experimental: Combined EA (cEA)combination of SI-EA and AI-EA
- Experimental: Control EA (Sham-EA)Sham electroacupuncture
Primary Outcome Measure
Changes in sympathetic and parasympathetic nervous systems [ Time Frame: through study completion, an average of 4.5 years ]
Central Contacts
- Ashwini Erande7144567025
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Susan Samueli Integrative Health Institute | Irvine | California | 92697 | LiFang Xie, PhD, LAc (SUB_INVESTIGATOR) Shaista Malik, MD, PhD, MPH (PRINCIPAL_INVESTIGATOR) Stephanie Tjen-A-Looi, PhD (PRINCIPAL_INVESTIGATOR) |
| University of California, Irvine, Health Sciences Medical Center | Orange | California | 92868 | Herlinda Bergman, M.Sc. 714-456-7090 |